1h Free Analyst Time
The publisher has been monitoring the predictive presymptomatic testing market and it is poised to grow by $2.45 bn during 2022-2026 progressing at a CAGR of 9.6% during the forecast period. The report on the predictive presymptomatic testing market provides a holistic analysis, of market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing healthcare spending worldwide, increasing demand for genetic counseling, and a rise in awareness toward early screening of genetic disorders.
The predictive presymptomatic testing market analysis includes application segment and geographic landscape.
The predictive presymptomatic testing market is segmented as below:
By Application
- Cancer diseases
- Genetic diseases
- Cardiovascular diseases
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing prevalence of genetic diseases as one of the prime reasons driving the predictive presymptomatic testing market growth during the next few years. Also, a rise in awareness toward early screening of genetic disorders, and advancements in genetic testing techniques will lead to sizable demand in the market.
The report on the predictive presymptomatic testing market covers the following areas:
- Predictive presymptomatic testing market sizing
- Predictive presymptomatic testing market forecast
- Predictive presymptomatic testing market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading predictive presymptomatic testing market vendors that include 23andMe Inc., Abbott Laboratories, Amgen Inc., BioAxis DNA Research Centre P Ltd., Color Genomics Inc., Deep Genomics, Direct Laboratory Services LLC, DNA and U, Editas Medicine Inc., Healius Ltd., Illumina Inc., International Business Machines Corp., Mapmygenome India Ltd., myDNA Life Ltd., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics Inc., Sysmex Corp., and Veritas Genetics Inc. Also, the predictive presymptomatic testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Application
5.1 Market segments
Exhibit 24: Chart on Application - Market share 2021-2026 (%)
Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
5.2 Comparison by Application
Exhibit 26: Chart on Comparison by Application
Exhibit 27: Data Table on Comparison by Application
5.3 Cancer diseases - Market size and forecast 2021-2026
Exhibit 28: Chart on Cancer diseases - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Cancer diseases - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Cancer diseases - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Cancer diseases - Year-over-year growth 2021-2026 (%)
5.4 Genetic diseases - Market size and forecast 2021-2026
Exhibit 32: Chart on Genetic diseases - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Genetic diseases - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Genetic diseases - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Genetic diseases - Year-over-year growth 2021-2026 (%)
5.5 Cardiovascular diseases - Market size and forecast 2021-2026
Exhibit 36: Chart on Cardiovascular diseases - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Cardiovascular diseases - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Cardiovascular diseases - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Cardiovascular diseases - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Application
Exhibit 40: Market opportunity by Application ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 Japan - Market size and forecast 2021-2026
Exhibit 70: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 France - Market size and forecast 2021-2026
Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 23andMe Inc.
Exhibit 89: 23andMe Inc. - Overview
Exhibit 90: 23andMe Inc. - Product / Service
Exhibit 91: 23andMe Inc. - Key offerings
10.4 Abbott Laboratories
Exhibit 92: Abbott Laboratories - Overview
Exhibit 93: Abbott Laboratories - Business segments
Exhibit 94: Abbott Laboratories - Key news
Exhibit 95: Abbott Laboratories - Key offerings
Exhibit 96: Abbott Laboratories - Segment focus
10.5 Color Genomics Inc.
Exhibit 97: Color Genomics Inc. - Overview
Exhibit 98: Color Genomics Inc. - Product / Service
Exhibit 99: Color Genomics Inc. - Key offerings
10.6 Direct Laboratory Services LLC
Exhibit 100: Direct Laboratory Services LLC - Overview
Exhibit 101: Direct Laboratory Services LLC - Product / Service
Exhibit 102: Direct Laboratory Services LLC - Key offerings
10.7 Healius Ltd.
Exhibit 103: Healius Ltd. - Overview
Exhibit 104: Healius Ltd. - Product / Service
Exhibit 105: Healius Ltd. - Key offerings
10.8 Mapmygenome India Ltd.
Exhibit 106: Mapmygenome India Ltd. - Overview
Exhibit 107: Mapmygenome India Ltd. - Product / Service
Exhibit 108: Mapmygenome India Ltd. - Key offerings
10.9 myDNA Life Ltd.
Exhibit 109: myDNA Life Ltd. - Overview
Exhibit 110: myDNA Life Ltd. - Product / Service
Exhibit 111: myDNA Life Ltd. - Key offerings
10.10 Myriad Genetics Inc.
Exhibit 112: Myriad Genetics Inc. - Overview
Exhibit 113: Myriad Genetics Inc. - Business segments
Exhibit 114: Myriad Genetics Inc. - Key offerings
Exhibit 115: Myriad Genetics Inc. - Segment focus
10.11 Quest Diagnostics Inc.
Exhibit 116: Quest Diagnostics Inc. - Overview
Exhibit 117: Quest Diagnostics Inc. - Business segments
Exhibit 118: Quest Diagnostics Inc. - Key offerings
Exhibit 119: Quest Diagnostics Inc. - Segment focus
10.12 Sysmex Corp.
Exhibit 120: Sysmex Corp. - Overview
Exhibit 121: Sysmex Corp. - Business segments
Exhibit 122: Sysmex Corp. - Key offerings
Exhibit 123: Sysmex Corp. - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 124: Inclusions checklist
Exhibit 125: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 126: Currency conversion rates for US$
11.4 Research methodology
Exhibit 127: Research methodology
Exhibit 128: Validation techniques employed for market sizing
Exhibit 129: Information sources
11.5 List of abbreviations
Exhibit 130: List of abbreviations
List of ExhibitsExhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Application - Market share 2021-2026 (%)
Exhibits 25: Data Table on Application - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Application
Exhibits 27: Data Table on Comparison by Application
Exhibits 28: Chart on Cancer diseases - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Cancer diseases - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Cancer diseases - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Cancer diseases - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Genetic diseases - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Genetic diseases - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Genetic diseases - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Genetic diseases - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on Cardiovascular diseases - Market size and forecast 2021-2026 ($ million)
Exhibits 37: Data Table on Cardiovascular diseases - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Chart on Cardiovascular diseases - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on Cardiovascular diseases - Year-over-year growth 2021-2026 (%)
Exhibits 40: Market opportunity by Application ($ million)
Exhibits 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 44: Chart on Geographic comparison
Exhibits 45: Data Table on Geographic comparison
Exhibits 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits 80: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits 82: Market opportunity By Geographical Landscape ($ million)
Exhibits 83: Impact of drivers and challenges in 2021 and 2026
Exhibits 84: Overview on Criticality of inputs and Factors of differentiation
Exhibits 85: Overview on factors of disruption
Exhibits 86: Impact of key risks on business
Exhibits 87: Vendors covered
Exhibits 88: Matrix on vendor position and classification
Exhibits 89: 23andMe Inc. - Overview
Exhibits 90: 23andMe Inc. - Product / Service
Exhibits 91: 23andMe Inc. - Key offerings
Exhibits 92: Abbott Laboratories - Overview
Exhibits 93: Abbott Laboratories - Business segments
Exhibits 94: Abbott Laboratories - Key news
Exhibits 95: Abbott Laboratories - Key offerings
Exhibits 96: Abbott Laboratories - Segment focus
Exhibits 97: Color Genomics Inc. - Overview
Exhibits 98: Color Genomics Inc. - Product / Service
Exhibits 99: Color Genomics Inc. - Key offerings
Exhibits 100: Direct Laboratory Services LLC - Overview
Exhibits 101: Direct Laboratory Services LLC - Product / Service
Exhibits 102: Direct Laboratory Services LLC - Key offerings
Exhibits 103: Healius Ltd. - Overview
Exhibits 104: Healius Ltd. - Product / Service
Exhibits 105: Healius Ltd. - Key offerings
Exhibits 106: Mapmygenome India Ltd. - Overview
Exhibits 107: Mapmygenome India Ltd. - Product / Service
Exhibits 108: Mapmygenome India Ltd. - Key offerings
Exhibits 109: myDNA Life Ltd. - Overview
Exhibits 110: myDNA Life Ltd. - Product / Service
Exhibits 111: myDNA Life Ltd. - Key offerings
Exhibits 112: Myriad Genetics Inc. - Overview
Exhibits 113: Myriad Genetics Inc. - Business segments
Exhibits 114: Myriad Genetics Inc. - Key offerings
Exhibits 115: Myriad Genetics Inc. - Segment focus
Exhibits 116: Quest Diagnostics Inc. - Overview
Exhibits 117: Quest Diagnostics Inc. - Business segments
Exhibits 118: Quest Diagnostics Inc. - Key offerings
Exhibits 119: Quest Diagnostics Inc. - Segment focus
Exhibits 120: Sysmex Corp. - Overview
Exhibits 121: Sysmex Corp. - Business segments
Exhibits 122: Sysmex Corp. - Key offerings
Exhibits 123: Sysmex Corp. - Segment focus
Exhibits 124: Inclusions checklist
Exhibits 125: Exclusions checklist
Exhibits 126: Currency conversion rates for US$
Exhibits 127: Research methodology
Exhibits 128: Validation techniques employed for market sizing
Exhibits 129: Information sources
Exhibits 130: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global predictive presymptomatic testing market: 23andMe Inc., Abbott Laboratories, Amgen Inc., BioAxis DNA Research Centre P Ltd., Color Genomics Inc., Deep Genomics, Direct Laboratory Services LLC, DNA and U, Editas Medicine Inc., Healius Ltd., Illumina Inc., International Business Machines Corp., Mapmygenome India Ltd., myDNA Life Ltd., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics Inc., Sysmex Corp., and Veritas Genetics Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the growing prevalence of genetic diseases.'
According to the report, one of the major drivers for this market is the increasing healthcare spending worldwide.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 23andMe Inc.
- Abbott Laboratories
- Amgen Inc.
- BioAxis DNA Research Centre P Ltd.
- Color Genomics Inc.
- Deep Genomics
- Direct Laboratory Services LLC
- DNA and U
- Editas Medicine Inc.
- Healius Ltd.
- Illumina Inc.
- International Business Machines Corp.
- Mapmygenome India Ltd.
- myDNA Life Ltd.
- Myriad Genetics Inc.
- NeoGenomics Laboratories Inc.
- Quest Diagnostics Inc.
- Sysmex Corp.
- Veritas Genetics Inc.
